<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Movano Inc — News on 6ix</title>
<link>https://6ix.com/company/movano-inc</link>
<description>Latest news and press releases for Movano Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 24 Mar 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/movano-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68359c6278dffbe2df10722b.webp</url>
<title>Movano Inc</title>
<link>https://6ix.com/company/movano-inc</link>
</image>
<item>
<title>CORVEX, INC. ANNOUNCES ADDITIONAL DETAILS OF SPECIAL 35.8% STOCK DIVIDEND FOR SHAREHOLDERS OF RECORD ON MARCH 30, 2026</title>
<link>https://6ix.com/company/movano-inc/news/corvex-inc-announces-additional-details-of-special-358percent-stock-dividend-for-shareholders-of-record-on-march-30-2026</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/corvex-inc-announces-additional-details-of-special-358percent-stock-dividend-for-shareholders-of-record-on-march-30-2026</guid>
<pubDate>Tue, 24 Mar 2026 12:00:00 GMT</pubDate>
<description>Corvex, Inc. (Nasdaq:MOVE) ("Corvex" or the "Company") today announced additional details regarding the special 35.8% stock dividend (the "Stock Dividend") previously announced on March 19, 2026.</description>
</item>
<item>
<title>CORVEX ANNOUNCES CLOSING OF ALL-STOCK MERGER</title>
<link>https://6ix.com/company/movano-inc/news/corvex-announces-closing-of-all-stock-merger</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/corvex-announces-closing-of-all-stock-merger</guid>
<pubDate>Tue, 24 Mar 2026 06:03:00 GMT</pubDate>
<description>Corvex, Inc. ("Corvex" or the "Company"), an AI cloud computing company specializing in GPU-accelerated infrastructure for AI workloads, today announced the completion of an all-stock merger (the "Merger") with Movano Inc. ("Movano"). The Merger marks the culmination of Corvex's plan to enter the public markets and underscores its emerging leadership addressing the three defining challenges of the AI era—more scale, more efficiency, and more security—via its Amplified AI Cloud™ platform. As glob</description>
</item>
<item>
<title>Corvex Launches Secure Model Weights, Delivering Hardware-Enforced Protection for AI Inference on Third-Party Infrastructure</title>
<link>https://6ix.com/company/movano-inc/news/corvex-launches-secure-model-weights-delivering-hardware-enforced-protection-for-ai-inference-on-third-party-infrastructure-20</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/corvex-launches-secure-model-weights-delivering-hardware-enforced-protection-for-ai-inference-on-third-party-infrastructure-20</guid>
<pubDate>Thu, 12 Mar 2026 22:01:00 GMT</pubDate>
<description>Corvex, Inc., an engineering-led AI infrastructure platform, today announced the early availability of Corvex Secure Model Weights, a patent-pending solution that enables AI model builders and enterprises to deploy inference workloads on third-party GPU infrastructure without exposing their model weights, which can be their most valuable intellectual property.</description>
</item>
<item>
<title>Corvex Among the First Companies to Achieve Verified Production Deployment of Confidential Computing for AI on NVIDIA HGX™ B200 Systems</title>
<link>https://6ix.com/company/movano-inc/news/corvex-among-the-first-companies-to-achieve-verified-production-deployment-of-confidential-computing-for-ai-on-nvidia-hgxtm-b200-systems-41</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/corvex-among-the-first-companies-to-achieve-verified-production-deployment-of-confidential-computing-for-ai-on-nvidia-hgxtm-b200-systems-41</guid>
<pubDate>Tue, 03 Mar 2026 21:05:00 GMT</pubDate>
<description>Corvex, Inc., an AI cloud computing company specializing in GPU-accelerated infrastructure for AI workloads, today announced it has completed and verified the production deployment of confidential computing on NVIDIA HGX B200 systems.</description>
</item>
<item>
<title>Corvex Secures Long-Term NVIDIA H200 GPU Deployment with AI-driven Provider of High-Performance Battery Technologies to Support Production AI Workloads</title>
<link>https://6ix.com/company/movano-inc/news/corvex-secures-long-term-nvidia-h200-gpu-deployment-with-ai-driven-provider-of-high-performance-battery-technologies-to-support-production-ai-workloads</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/corvex-secures-long-term-nvidia-h200-gpu-deployment-with-ai-driven-provider-of-high-performance-battery-technologies-to-support-production-ai-workloads</guid>
<pubDate>Thu, 22 Jan 2026 21:05:00 GMT</pubDate>
<description>Corvex, Inc., an AI cloud computing company specializing in GPU-accelerated infrastructure for AI workloads, today announced a long-term GPU lease agreement with an established AI-driven provider of high-performance battery technologies.</description>
</item>
<item>
<title>CORVEX TO GO PUBLIC IN ALL-STOCK MERGER WITH MOVANO, CREATING A PURE-PLAY PLATFORM FOR SECURE AI INFRASTRUCTURE AND HIGH-PERFORMANCE INFERENCE</title>
<link>https://6ix.com/company/movano-inc/news/corvex-to-go-public-in-all-stock-merger-with-movano-creating-a-pure-play-platform-for-secure-ai-infrastructure-and-high-performance-inference</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/corvex-to-go-public-in-all-stock-merger-with-movano-creating-a-pure-play-platform-for-secure-ai-infrastructure-and-high-performance-inference</guid>
<pubDate>Mon, 10 Nov 2025 05:00:00 GMT</pubDate>
<description>Strategic combination positions combined company to capture AI infrastructure demand at scale Movano (Nasdaq: MOVE) shareholders gain exposure to rapidly</description>
</item>
<item>
<title>Movano Health Announces Reverse Stock Split</title>
<link>https://6ix.com/company/movano-inc/news/movano-health-announces-reverse-stock-123000118</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/movano-health-announces-reverse-stock-123000118</guid>
<pubDate>Wed, 08 Oct 2025 12:30:00 GMT</pubDate>
<description>Movano Health (Nasdaq: MOVE) announced today that it will implement a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split"), effective at 12:01 a.m. Eastern time on October 10, 2025. The Company's common stock is expected to begin trading on a split-adjusted basis when the market opens on Friday, October 10, 2025, and will continue to trade on The Nasdaq Capital Market under the symbol "MOVE." The new CUSIP number for the common stock will be 62459M 305.</description>
</item>
<item>
<title>Movano Health Granted Listing Extension by Nasdaq</title>
<link>https://6ix.com/company/movano-inc/news/movano-health-granted-listing-extension-203000192</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/movano-health-granted-listing-extension-203000192</guid>
<pubDate>Thu, 28 Aug 2025 20:30:00 GMT</pubDate>
<description>Movano Health (Nasdaq: MOVE)(the "Company") announced today that, by letter received on August 27, 2025, the Nasdaq Hearings Panel (the "Panel") of The Nasdaq Stock Market LLC ("Nasdaq") has determined to grant the Company's request to continue its listing on Nasdaq, subject to (i) the Company regaining compliance with Listing Rule 5250(c)(1), requiring the timely filing of periodic reports (the "Period Filing Rule"), by filing its Quarterly Reports on Form 10-Q for the quarters ended March 31,</description>
</item>
<item>
<title>Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q</title>
<link>https://6ix.com/company/movano-inc/news/movano-health-receives-notification-deficiency-201500536</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/movano-health-receives-notification-deficiency-201500536</guid>
<pubDate>Fri, 22 Aug 2025 20:15:00 GMT</pubDate>
<description>Movano Health (Nasdaq: MOVE)(the "Company") announced today that it received a notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") indicating that because the Company had not yet filed its Form 10-Q for the quarterly period ended June 30, 2025 (the "Form 10-Q"), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Filing Requirement") requiring Nasdaq-listed companies to timely file all periodic financial reports with the</description>
</item>
<item>
<title>Movano Health Plans to Timely Request a Hearing Before a Nasdaq Hearings Panel</title>
<link>https://6ix.com/company/movano-inc/news/movano-health-plans-timely-request-213000372</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/movano-health-plans-timely-request-213000372</guid>
<pubDate>Fri, 11 Jul 2025 21:30:00 GMT</pubDate>
<description>Movano Health (Nasdaq: MOVE) (the "Company") announced today that, on July 7, 2025, it received a delisting determination from The Nasdaq Capital Market with respect to the $1.00 per share bid price requirement (the "Bid Price Requirement"), as set forth in Listing Rule 5550(a)(2), and the late filing requirement, as set forth in Listing Rule 5250(c)(1), given the delay in filing its Form 10-Q for the quarter ended March 31, 2025 (the "Filing Requirement")(together, the "Notice"). Accordingly, t</description>
</item>
<item>
<title>Movano Health's Board of Directors Initiates Process to Maximize Shareholder Value</title>
<link>https://6ix.com/company/movano-inc/news/movano-healths-board-directors-initiates-203000109</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/movano-healths-board-directors-initiates-203000109</guid>
<pubDate>Fri, 16 May 2025 20:30:00 GMT</pubDate>
<description>Movano Health (Nasdaq: MOVE), a pioneer in health technology, announced today that its Board of Directors has initiated a process to explore strategic alternatives, including a sale, merger or similar transaction involving the Company, to maximize shareholder value. To support this process, Movano Health's Board of Directors has engaged Aquilo Partners as its financial advisor and K&L Gates LLP as its legal counsel.</description>
</item>
<item>
<title>Movano Health's Proprietary Cuffless Blood Pressure Device Once Again Achieves Accuracy Commensurate with the FDA's Requirements</title>
<link>https://6ix.com/company/movano-inc/news/movano-healths-proprietary-cuffless-blood-120000731</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/movano-healths-proprietary-cuffless-blood-120000731</guid>
<pubDate>Tue, 22 Apr 2025 12:00:00 GMT</pubDate>
<description>Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced positive results of its most recent 81-participant blood pressure clinical study. Movano Health's prototype demonstrated a level of accuracy well within the standards recognized by the FDA for blood pressure monitoring devices, achieving an overall mean absolute difference (MAD) of 4.9 mmHg, which significantly exceeds the 7 mmHg MAD threshold required per a standard for wearable, cuffless blood pressure measuring devi</description>
</item>
<item>
<title>Movano's Evie Ring Adds New Personalization and Trend Tracking to Support Women's Wellness Journey</title>
<link>https://6ix.com/company/movano-inc/news/movanos-evie-ring-adds-personalization-120000349</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/movanos-evie-ring-adds-personalization-120000349</guid>
<pubDate>Mon, 10 Mar 2025 12:00:00 GMT</pubDate>
<description>Movano Health (Nasdaq: MOVE), a pioneer in health technology and maker of the Evie Ring, today announced a series of new data personalization, trend tracking and integration features on the ring's companion app that expand support for women's wellness journeys. The enhancements follow January's beta release of EvieAI, the first wearable-based virtual wellness assistant built exclusively with training data from medical journals.</description>
</item>
<item>
<title>Movano Health Commences Clinical Study with New Cuffless Blood Pressure Device</title>
<link>https://6ix.com/company/movano-inc/news/movano-health-commences-clinical-study-with-new-cuffless-blood-pressure-device</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/movano-health-commences-clinical-study-with-new-cuffless-blood-pressure-device</guid>
<pubDate>Tue, 04 Feb 2025 05:00:00 GMT</pubDate>
<description>New proprietary RF hardware delivers significantly enhanced signal fidelity PLEASANTON, Calif., Feb. 4, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE)</description>
</item>
<item>
<title>Movano Health Launches EvieAI Virtual Wellness Assistant</title>
<link>https://6ix.com/company/movano-inc/news/movano-health-launches-evieai-virtual-wellness-assistant</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/movano-health-launches-evieai-virtual-wellness-assistant</guid>
<pubDate>Wed, 08 Jan 2025 05:00:00 GMT</pubDate>
<description>Newest Evie Ring feature is the first medical journal trained AI companion in a wearable PLEASANTON, Calif., Jan. 8, 2025 /PRNewswire/ -- Movano Health</description>
</item>
<item>
<title>Movano Health Welcomes Dr. Shaheen Wirk to its Board of Directors</title>
<link>https://6ix.com/company/movano-inc/news/movano-health-welcomes-dr-shaheen-wirk-to-its-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/movano-health-welcomes-dr-shaheen-wirk-to-its-board-of-directors</guid>
<pubDate>Thu, 02 Jan 2025 05:00:00 GMT</pubDate>
<description>PLEASANTON, Calif., Jan. 2, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced the expansion of its board of</description>
</item>
<item>
<title>Movano Health Receives FDA Clearance for EvieMED Ring</title>
<link>https://6ix.com/company/movano-inc/news/movano-health-receives-fda-clearance-for-eviemed-ring</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/movano-health-receives-fda-clearance-for-eviemed-ring</guid>
<pubDate>Mon, 02 Dec 2024 05:00:00 GMT</pubDate>
<description>Company's first 510(k) clearance unlocks a TAM of $40 billion in healthcare B2B opportunities PLEASANTON, Calif., Dec. 2, 2024 /PRNewswire/ -- Movano Health</description>
</item>
<item>
<title>Movano Health Reports Q3 2024 Financial Results and Provides Business Update</title>
<link>https://6ix.com/company/movano-inc/news/movano-health-reports-q3-2024-financial-results-and-provides-business-update</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/movano-health-reports-q3-2024-financial-results-and-provides-business-update</guid>
<pubDate>Thu, 14 Nov 2024 05:00:00 GMT</pubDate>
<description>Highlights successful Evie Ring back-in-stock execution Updates status of EvieMED 510(k) application review Focuses on launch of EvieMED and securing B2B</description>
</item>
<item>
<title>Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device</title>
<link>https://6ix.com/company/movano-inc/news/movano-health-announces-completion-of-clinical-study-with-cuffless-rf-blood-pressure-device</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/movano-health-announces-completion-of-clinical-study-with-cuffless-rf-blood-pressure-device</guid>
<pubDate>Thu, 07 Nov 2024 05:00:00 GMT</pubDate>
<description>New hardware boasts significant improvements to reduce noise and generate higher fidelity signals PLEASANTON, Calif., Nov. 7, 2024 /PRNewswire/ -- Movano</description>
</item>
<item>
<title>Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024</title>
<link>https://6ix.com/company/movano-inc/news/movano-health-to-report-third-quarter-2024-financial-results-on-thursday-november-14-2024</link>
<guid isPermaLink="true">https://6ix.com/company/movano-inc/news/movano-health-to-report-third-quarter-2024-financial-results-on-thursday-november-14-2024</guid>
<pubDate>Wed, 06 Nov 2024 05:00:00 GMT</pubDate>
<description>Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif., Nov. 6, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today</description>
</item>
</channel>
</rss>